EOLS
Evolus, Inc. NASDAQ Listed Feb 8, 2018$7.86
After hrs
$7.86
+0.00%
Mkt Cap $506.7M
52w Low $3.94
73.1% of range
52w High $9.30
50d MA $7.61
200d MA $6.14
P/E (TTM)
-15.2x
EV/EBITDA
—
P/B
—
Debt/Equity
-6.7x
ROE
223.5%
P/FCF
-11.1x
RSI (14)
29.10
ATR (14)
$0.37
Beta
1.00
50d MA
$7.61
200d MA
$6.14
Avg Volume
871.3K
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorporated in 2012 and is headquartered in Newport Beach, California.
520 Newport Center Drive · Newport Beach, CA 92660 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | AMC | -0.04 | -0.12 | -179.9% | 6.18 | +13.1% | +19.9% | +2.4% | -0.3% | +10.2% | -2.6% | — |
| May 4, 2026 | AMC | -0.14 | -0.10 | +28.6% | 5.58 | -2.3% | +14.2% | -0.8% | +1.1% | -0.5% | -0.6% | — |
| Mar 3, 2026 | AMC | 0.06 | 0.04 | -26.3% | 4.13 | +30.0% | +35.4% | +1.3% | -2.3% | -3.3% | -1.3% | — |
| Nov 5, 2025 | AMC | -0.19 | -0.14 | +26.3% | 6.81 | +12.9% | +5.4% | -8.6% | +7.5% | -0.9% | +4.4% | — |
| Aug 5, 2025 | AMC | -0.09 | -0.24 | -166.7% | 8.91 | -24.2% | -28.5% | -4.7% | -2.8% | -2.2% | +10.9% | — |
| May 7, 2025 | AMC | -0.10 | -0.18 | -80.0% | 11.76 | -5.2% | -14.2% | -2.9% | +1.8% | +1.5% | -1.4% | — |
| Mar 4, 2025 | AMC | 0.02 | 0.01 | -50.0% | 14.35 | +1.0% | -1.3% | -4.7% | +0.6% | -6.6% | +0.2% | — |
| Nov 6, 2024 | AMC | -0.08 | -0.19 | -137.5% | 16.81 | -9.2% | -15.0% | -4.3% | -4.1% | -5.2% | -1.5% | — |
| Jul 31, 2024 | AMC | -0.06 | -0.07 | -23.0% | 12.42 | +12.7% | +13.0% | -1.3% | -4.0% | -2.9% | -0.2% | — |
| May 7, 2024 | AMC | -0.07 | -0.13 | -85.7% | 13.42 | -2.0% | -1.2% | -1.0% | -2.9% | -1.1% | +1.3% | — |
| Mar 7, 2024 | AMC | -0.07 | -0.14 | -100.0% | 14.79 | -2.3% | -4.9% | -0.4% | +0.6% | -0.4% | +0.2% | — |
| Nov 7, 2023 | AMC | -0.22 | -0.19 | +13.6% | 8.08 | +14.5% | +8.2% | -5.1% | -3.5% | +1.5% | +4.1% | — |
| Aug 2, 2023 | AMC | -0.22 | -0.22 | +0.0% | 9.84 | +4.7% | +2.1% | -1.7% | -5.6% | +0.8% | -1.4% | — |
| May 9, 2023 | AMC | -0.13 | -0.17 | -30.8% | 9.07 | +5.0% | +16.0% | -2.1% | -0.4% | +0.6% | -5.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4 | BTIG | Maintains | Buy → Buy | — | $4.13 | $5.37 | +30.0% | +35.4% | +1.3% | -2.3% | -3.3% | -1.3% |
| Feb 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $4.91 | $4.87 | -0.8% | -4.3% | -2.3% | -3.9% | +2.0% | -5.8% |
| Jan 22 | BTIG | Maintains | Buy → Buy | — | $4.90 | $4.94 | +0.8% | +3.7% | -3.1% | -2.0% | +2.7% | -3.0% |
| Jan 13 | Stifel | Maintains | Buy → Buy | — | $5.77 | $5.74 | -0.5% | -0.9% | -12.2% | -0.4% | +4.0% | -2.7% |
| Jan 9 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $5.74 | $5.64 | -1.7% | -1.6% | +2.1% | -0.9% | -12.2% | -0.4% |
| Dec 24 | Needham | Maintains | Hold → Hold | — | $6.81 | $6.80 | -0.1% | +0.6% | +0.7% | -3.5% | +0.2% | -0.3% |
| Dec 2 | Mizuho | Maintains | Outperform → Outperform | — | $6.82 | $6.82 | +0.0% | -4.4% | +3.5% | +0.9% | +0.6% | +1.8% |
| Sep 8 | BTIG | Maintains | Buy → Buy | — | $7.66 | $7.61 | -0.7% | -0.7% | -2.9% | -0.5% | +2.2% | -4.3% |
| Aug 6 | Needham | Downgrade | Buy → Hold | — | $8.91 | $6.75 | -24.2% | -28.5% | -4.7% | -2.8% | -2.2% | +10.9% |
| Aug 6 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $8.91 | $6.75 | -24.2% | -28.5% | -4.7% | -2.8% | -2.2% | +10.9% |
| Aug 6 | BTIG | Maintains | Buy → Buy | — | $8.91 | $6.75 | -24.2% | -28.5% | -4.7% | -2.8% | -2.2% | +10.9% |
| May 8 | Needham | Maintains | Buy → Buy | — | $11.76 | $11.15 | -5.2% | -14.2% | -2.9% | +1.8% | +1.5% | -1.4% |
| Apr 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.37 | $9.91 | -4.4% | -9.3% | +1.4% | +7.7% | -0.4% | -1.2% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $9.36 | $9.13 | -2.5% | +10.8% | -9.3% | +1.4% | +7.7% | -0.4% |
| Mar 5 | Barclays | Maintains | Overweight → Overweight | — | $14.35 | $14.50 | +1.0% | -1.3% | -4.7% | +0.6% | -6.6% | +0.2% |
| Mar 5 | Needham | Maintains | Buy → Buy | — | $14.35 | $14.50 | +1.0% | -1.3% | -4.7% | +0.6% | -6.6% | +0.2% |
| Mar 5 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.35 | $14.50 | +1.0% | -1.3% | -4.7% | +0.6% | -6.6% | +0.2% |
| Feb 14 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $15.04 | $15.20 | +1.1% | -2.0% | +0.3% | +0.6% | -1.7% | -4.3% |
| Jan 27 | Barclays | Maintains | Overweight → Overweight | — | $14.23 | $14.23 | +0.0% | +3.7% | -3.6% | +2.3% | -2.4% | -1.7% |
| Jan 22 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.48 | $13.68 | +1.5% | +4.8% | -0.8% | +1.5% | +3.7% | -3.6% |
| Jan 21 | Needham | Maintains | Buy → Buy | — | $10.51 | $12.98 | +23.5% | +28.3% | +4.8% | -0.8% | +1.5% | +3.7% |
| Nov 7 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.81 | $15.26 | -9.2% | -15.0% | -4.3% | -4.1% | -5.2% | -1.5% |
| Nov 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $16.32 | $16.41 | +0.6% | +2.6% | -2.0% | +0.4% | +1.9% | -15.0% |
| Oct 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $17.14 | $17.32 | +1.1% | -0.5% | -4.2% | +0.9% | +0.1% | +1.6% |
| Sep 13 | Needham | Maintains | Buy → Buy | — | $16.46 | $16.80 | +2.1% | +6.3% | -4.1% | +0.7% | -4.0% | +1.4% |
| Sep 13 | Barclays | Maintains | Overweight → Overweight | — | $16.46 | $16.80 | +2.1% | +6.3% | -4.1% | +0.7% | -4.0% | +1.4% |
| Aug 1 | Needham | Maintains | Buy → Buy | — | $12.42 | $14.00 | +12.7% | +13.0% | -1.3% | -4.0% | -2.9% | -0.2% |
| Aug 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $12.42 | $14.00 | +12.7% | +13.0% | -1.3% | -4.0% | -2.9% | -0.2% |
| May 21 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.42 | $13.38 | -0.3% | -1.9% | -1.7% | -3.8% | +0.5% | +1.0% |
| May 8 | Needham | Maintains | Buy → Buy | — | $13.42 | $13.15 | -2.0% | -1.2% | -1.0% | -2.9% | -1.1% | +1.3% |
| May 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $13.42 | $13.15 | -2.0% | -1.2% | -1.0% | -2.9% | -1.1% | +1.3% |
| Apr 10 | Needham | Maintains | Buy → Buy | — | $13.29 | $13.00 | -2.2% | -3.9% | -0.6% | -4.7% | -1.7% | +1.3% |
| Mar 8 | Needham | Maintains | Buy → Buy | — | $14.79 | $14.45 | -2.3% | -4.9% | -0.4% | +0.6% | -0.4% | +0.2% |
| Mar 8 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.79 | $14.45 | -2.3% | -4.9% | -0.4% | +0.6% | -0.4% | +0.2% |
| Mar 8 | Stifel | Maintains | Buy → Buy | — | $14.79 | $14.45 | -2.3% | -4.9% | -0.4% | +0.6% | -0.4% | +0.2% |
| Mar 8 | Mizuho | Maintains | Buy → Buy | — | $14.79 | $14.45 | -2.3% | -4.9% | -0.4% | +0.6% | -0.4% | +0.2% |
| Mar 1 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $14.83 | $14.83 | +0.0% | +0.5% | -1.1% | -1.2% | -3.2% | +4.8% |
| Jan 29 | Barclays | Upgrade | Equal Weight → Overweight | — | $11.94 | $12.68 | +6.2% | +12.8% | -3.7% | -2.2% | +2.8% | +3.3% |
| Jan 17 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.43 | $11.00 | +5.5% | +19.7% | -5.1% | +0.1% | +2.0% | -2.8% |
| Dec 20 | Needham | Maintains | Buy → Buy | — | $9.84 | $10.14 | +3.0% | -1.6% | +3.1% | -0.2% | +0.7% | +1.2% |
| Aug 3 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.84 | $10.30 | +4.7% | +2.1% | -1.7% | -5.6% | +0.8% | -1.4% |
| Aug 3 | Needham | Maintains | Buy → Buy | — | $9.84 | $10.30 | +4.7% | +2.1% | -1.7% | -5.6% | +0.8% | -1.4% |
| Jul 28 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $10.13 | $10.26 | +1.3% | +0.0% | -1.1% | +1.5% | -3.2% | +2.1% |
| Jun 7 | Mizuho | Maintains | Buy → Buy | — | $8.74 | $8.78 | +0.5% | +0.1% | -1.9% | -3.0% | -1.1% | -1.9% |
| May 26 | Truist | Maintains | Buy → Buy | — | $8.98 | $9.06 | +0.9% | -2.2% | +2.5% | +0.6% | -4.2% | +2.3% |
| May 10 | HC Wainwright & Co. | Maintains | Buy → Buy | — | $9.07 | $9.52 | +5.0% | +16.0% | -2.1% | -0.4% | +0.6% | -5.9% |
| May 10 | Needham | Maintains | Buy → Buy | — | $9.07 | $9.52 | +5.0% | +16.0% | -2.1% | -0.4% | +0.6% | -5.9% |
| Jan 19 | SVB Leerink | Maintains | Outperform → Outperform | — | $9.99 | $10.17 | +1.8% | +5.3% | +5.0% | -0.2% | -2.2% | +2.3% |
| Jan 19 | Mizuho | Maintains | Buy → Buy | — | $9.99 | $10.17 | +1.8% | +5.3% | +5.0% | -0.2% | -2.2% | +2.3% |
| May 13 | Barclays | Upgrade | Underweight → Equal Weight | — | $12.04 | $12.07 | +0.2% | +9.5% | +4.1% | +1.6% | -11.5% | -2.3% |
No insider trades available.
8-K · 1.01
!! High
Evolus, Inc. -- 8-K 1.01: Material Agreement
Aug 4
8-K · 1.01
!! High
Evolus, Inc. -- 8-K 1.01: Material Agreement
Evolus secured exclusive U.S. licensing rights to IBSA's Profhilo product with potential to negotiate additional brand extensions, expanding its aesthetic medicine portfolio.
Jul 8
8-K
Evolus, Inc. -- 8-K Filing
Jun 12
8-K · 5.02
!!! Very High
Unknown — 8-K 5.02: Executive Change
The departure of Class II director Malik may signal leadership instability at EOLS, potentially affecting governance quality and investor confidence in the company's strategic direction.
Mar 13
8-K · 1.01
! Medium
Evolus, Inc. -- 8-K 1.01: Financing / Debt Agreement
Evolus secured $30 million in debt financing from Eclipse Business Capital LLC, providing liquidity for operations but increasing the company's leverage obligations.
Mar 3
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 4,840,828 | $34M | New | Jun 2026 |
| 2 | Braidwell Lp | 3,105,209 | $21M | New | Dec 2025 |
| 3 | Vanguard Capital Management Llc | 2,362,893 | $16M | Reduced | Jun 2026 |
| 4 | Millennium Management Llc | 1,787,929 | $12M | Added | Jun 2026 |
| 5 | Point72 Asset Management, L.p. | 1,508,518 | $10M | New | Jun 2026 |
| 6 | Morgan Stanley | 1,461,330 | $10M | Added | Dec 2025 |
| 7 | Tang Capital Management Llc | 1,245,692 | $8M | Reduced | Dec 2025 |
| 8 | Rice Hall James & Associates, Llc | 1,153,444 | $8M | Reduced | Dec 2025 |
| 9 | Citadel Advisors Llc | 1,012,708 | $7M | Reduced | Jun 2026 |
| 10 | Assenagon Asset Management S.a. | 908,180 | $6M | Added | Jun 2026 |
| 11 | Soleus Capital Management, L.p. | 822,428 | $6M | Reduced | Jun 2026 |
| 12 | Pinnacle Associates Ltd | 1,158,895 | $5M | Added | Mar 2026 |
| 13 | Vanguard Portfolio Management Llc | 545,702 | $4M | Added | Jun 2026 |
| 14 | Ubs Group Ag | 752,881 | $3M | Reduced | Mar 2026 |
| 15 | Cm Management, Llc | 400,000 | $3M | Added | Jun 2026 |
| 16 | Jane Street Group, Llc | 417,278 | $3M | Added | Dec 2025 |
| 17 | D. E. Shaw & Co., Inc. | 336,901 | $2M | Reduced | Jun 2026 |
| 18 | Renaissance Technologies Llc | 302,569 | $2M | Reduced | Jun 2026 |
| 19 | Northern Trust Corp | 472,343 | $2M | Added | Mar 2026 |
| 20 | Walleye Capital Llc | 253,817 | $2M | New | Jun 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$506.7M
Enterprise Value
$599.0M
P/E (TTM)
-15.17x
Forward P/E
—
PEG Ratio
6.72x
P/B
—
P/S
1.60x
P/FCF
-11.09x
EV/EBITDA
—
Shares Out
64.5M
Financials (TTM)
Revenue
$316.5M
Net Income
-$34.3M
EBITDA
-$10.2M
Free Cash Flow
-$45.7M
Op Cash Flow
-$42.3M
EPS Basic
$-0.80
EPS Diluted
$-0.52
EPS Forward
$-0.09
Gross Margin
66.2%
Op Margin
-7.3%
Net Margin
-10.8%
Balance Sheet
Total Assets
$225.9M
Total Liab.
$249.0M
Total Equity
-$23.1M
Cash
$53.8M
LT Debt
$146.1M
Book Value/Sh
$-0.36
Debt/Equity
-6.71x
Current Ratio
1.90
Quick Ratio
1.54
Returns & Growth
ROE
223.5%
ROA
-22.9%
ROIC
-24.6%
Rev Growth YoY
+11.6%
EPS Growth YoY
+1.2%
Price Returns
2W
-6.7%
1M
-8.9%
3M
+14.8%
6M
+80.6%
12M
+31.4%
Technicals
52W High
$9.30
52W Low
$3.94
50d MA
$7.61
200d MA
$6.14
RSI (14)
29.10
ATR (14)
$0.37
Beta
1.00
Avg Volume
871K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$15.00
High
$17.00
Low
$13.00
Median
$15.00
Data updated apr 25, 2026 7:19am
· Source: financialmodelingprep.com